• Reliable Cell Proliferation with EdU Imaging Kits (HF594)

  2026-06-04

  This article delivers a scenario-driven, evidence-based exploration of EdU Imaging Kits (HF594) (SKU K2243) for sensitive, reproducible cell proliferation and DNA synthesis assays. Drawing from practical laboratory challenges and peer-reviewed literature, we demonstrate how the kit’s click chemistry workflow ensures superior data quality and workflow safety, empowering researchers in cancer, immunology, and drug screening applications.

• Okadaic acid (A4540): Protocol Parameters and Lab Best Pract

  2026-06-04

  Okadaic acid provides precise, nanomolar-range inhibition of protein phosphatase 1 (PP1) and PP2A, enabling the study of phosphorylation-dependent pathways and controlled induction of apoptosis in cell models. It is not suitable for applications requiring broad-spectrum phosphatase inhibition or where off-target effects are undesirable. Researchers should adopt strict handling and assay protocols to maximize reproducibility and safety.

• α2-Adrenergic Receptor Agonists in Post-Surgery Osteosarcoma

  2026-06-03

  The reference study demonstrates that α2-adrenergic receptor agonists, delivered via a thermo-sensitive hydrogel, significantly reduce immune rejection and tumor recurrence after osteosarcoma surgery by enhancing CD8+ T cell-mediated anti-tumor immunity. These findings suggest a new immunomodulatory strategy for improving clinical outcomes in osteosarcoma management.

• SARS-CoV-2 Nucleocapsid Protein Disrupts GADD34-Mediated Imm

  2026-06-03

  This study reveals that the SARS-CoV-2 nucleocapsid protein impairs the host’s innate immune response by antagonizing GADD34-mediated pathways through the formation of atypical stress granule-like foci. These findings illuminate a novel viral immune evasion strategy, highlighting GADD34 sequestration as a potential target for future antiviral research.

• FOXM1–Estrogen Receptor Interaction in Female Lung Adenocarc

  2026-06-02

  This study reveals a novel ceRNA network involving FOXM1 and estrogen receptor 1 in female lung adenocarcinoma, highlighting how FOXM1 expression shapes tumor progression and immunotherapy sensitivity. The findings provide a mechanistic basis for biomarker discovery and targeted research on estrogen receptor signaling in lung cancer.

• SREBP-1c Disrupts ULK1 Sulfhydration and Autophagy in NAFLD

  2026-06-02

  Nguyen et al. (2021) demonstrate that SREBP-1c impairs autophagic lipid degradation in high-fat-diet-fed mice by suppressing CSE/H2S-mediated sulfhydration of ULK1, thereby promoting hepatic steatosis. This mechanistic insight highlights the dual role of SREBP-1c in regulating both lipid synthesis and degradation, providing a refined understanding of non-alcoholic fatty liver disease (NAFLD) pathogenesis.

• Okadaic Acid (A4540): Practical Use as a PP1 Inhibitor

  2026-06-01

  Okadaic acid is a selective, marine-derived inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), enabling precise modulation of phosphorylation-dependent signaling in apoptosis and cancer research. It is best suited for protocols requiring targeted, nanomolar-range phosphatase inhibition, but should not be used where broad-spectrum phosphatase inhibition or unconventional solvents are necessary.

• CDC42-Driven Polarity Regulates Intestinal Stem Cell Fate vi

  2026-06-01

  The reference study demonstrates that CDC42-dependent apical-basal polarity orchestrates the transition from intestinal stem cells (ISCs) to transit amplifying (TA) cells through a Hippo-YAP-EGF-mTOR signaling cascade, independent of canonical Wnt pathways. These findings clarify the molecular framework underlying epithelial homeostasis, providing actionable targets for gastrointestinal research and stem cell modulation.

• DAPI Solution (1 mg/mL): Optimizing Nuclear Visualization Wo

  2026-05-31

  Unlock the full potential of 4',6-Diamidino-2-Phenylindole for apoptosis detection, viability assessment, and high-fidelity nuclear visualization. This guide bridges advanced PAD4 inhibitor research with actionable DAPI workflow enhancements, addressing protocol precision and troubleshooting for both fluorescence microscopy and flow cytometry.

• Fluconazole: Applied Workflows & Resistance Insights in Cand

  2026-05-30

  Fluconazole stands as the benchmark fungal cytochrome P450 enzyme 14α-demethylase inhibitor for dissecting antifungal susceptibility and drug resistance in Candida albicans. This article distills advanced protocols, troubleshooting strategies, and the latest mechanistic findings—empowering researchers to maximize reproducibility in antifungal and biofilm studies.

• SIRT3–SUMO Control of Treg Differentiation in Asthma via N-G

  2026-05-29

  This study reveals how SIRT3-SUMO regulates Treg cell differentiation and asthma progression by modulating N-glycosylation through the fatty acid oxidation pathway. The findings provide mechanistic insight into immune regulation in asthma and highlight new avenues for targeted intervention.

• ETS1 Modulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis

  2026-05-29

  This article reviews a recent study identifying ETS1 as a key transcriptional regulator that protects against bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 pathway. These findings provide new mechanistic insights into chaperone-mediated autophagy in lung development and highlight potential molecular targets for BPD intervention.

• GSTA1 Drives Glutathione Loss in α-Amanitin Hepatotoxicity

  2026-05-28

  This study uncovers a paradoxical mechanism in which GSTA1, typically an antioxidant enzyme, exacerbates α-amanitin-induced liver injury by depleting glutathione and intensifying oxidative stress. The findings redefine GSTA1’s role in hepatic toxicity and suggest new therapeutic targets for acute liver injury research.

• Protease Inhibitor Cocktail: Safeguarding Protein Extraction

  2026-05-28

  The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO delivers broad-spectrum protein degradation prevention in even the most challenging extraction workflows. Discover how this solution elevates assay reproducibility and data integrity, with actionable protocol enhancements and troubleshooting strategies drawn from cutting-edge oncology research.

• Okadaic Acid (A4540): Protocols and QC for PP1/PP2A Inhibiti

  2026-05-27

  Okadaic acid is a potent inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), widely used to dissect phosphorylation-dependent signaling and apoptosis in cell biology and cancer research. It provides robust, nanomolar-range inhibition, but its strong activity and solvent formulation demand precise handling and protocol optimization. Okadaic acid should be avoided in contexts where non-specific phosphatase inhibition or solvent interference could compromise results.

8413 records 10/561 page Previous Next First page 上5页 678910 下5页 Last page